LOGIN  |  REGISTER
Assertio

Phreesia (NYSE: PHR) Stock Quote

Last Trade: US$23.14 0.73 3.26
Volume: 373,551
5-Day Change: 1.71%
YTD Change: -0.04%
Market Cap: US$1.300B

Latest News From Phreesia

ALL-REMOTE COMPANY/WILMINGTON, Del. / Mar 19, 2024 / Business Wire / Phreesia , a leader in patient intake, outreach and activation, has named Jack Callahan as the company’s new Chief Technology Officer. Callahan previously served as Phreesia’s Vice President of Engineering and has been with the company for 14 years. He succeeds Dan Nathan, who has been with the company for 17 years and played an integral role in... Read More
WILMINGTON, Del. / Mar 14, 2024 / Business Wire / Phreesia, Inc . (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024. "Phreesia ended fiscal year 2024 with strong momentum going into fiscal 2025. We facilitated more than 150 million patient visits in fiscal 2024, or more than one in ten patient visits across the U.S. We are... Read More
WILMINGTON, Del. / Feb 27, 2024 / Business Wire / Phreesia is proud to announce that its Chief Clinical Officer Hilary Hatch, PhD, has been selected to participate in the National Quality Forum (NQF)’s 2024-2025 Leadership Consortium . Dr. Hatch is one of only 29 healthcare leaders included in the prestigious group, underscoring her dedication to healthcare quality and patient-centered care. She was first named to the group... Read More
32% of Patients Who Saw a Breast Cancer-Prevention Campaign Requested a Screening WILMINGTON, Del. / Feb 20, 2024 / Business Wire / Phreesia , a leader in patient intake, outreach and activation, is proud to release data from an analysis of its cancer prevention campaigns illustrating the significant impact its platform can have on increasing rates of cancer screenings. By engaging patients at critical moments in their... Read More
WILMINGTON, Del. / Feb 05, 2024 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal fourth quarter 2024 financial results after the close of market trading on Thursday, March 14, 2024. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com... Read More
WILMINGTON, Del. / Jan 23, 2024 / Business Wire / Phreesia , a leader in patient intake, outreach and activation, is pleased to announce that it has joined the National Adult and Influenza Immunization Summit’s Call to Action for Adult Immunizations campaign to improve adult vaccination rates. More than three in four adults are missing routinely recommended vaccines and, due to preventive care put on hold during the COVID-19... Read More
WILMINGTON, Del. / Jan 16, 2024 / Business Wire / Phreesia , a leader in patient intake, outreach and activation, is proud to announce that Audrey Gato, Vice President of Client Solutions, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2023. Honorees were chosen based on their leadership and contributions to the Software-as-a-Service industry. This is the sixth consecutive year a female... Read More
WILMINGTON, Del. / Jan 11, 2024 / Business Wire / Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named the Post-Script Engagement, Phreesia’s new medication adherence solution, to its list of 2023 Most Innovative Marketing Technologies or Services. Over the last decade, PM360’s annual Innovations Issue has spotlighted the pharma industry’s most innovative companies,... Read More
WILMINGTON, Del. / Dec 05, 2023 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2023. "I am proud of our work during the third quarter to further our mission of helping patients take a more active role in their care," said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations website at... Read More
WILMINGTON, Del. / Dec 01, 2023 / Business Wire / Phreesia is very pleased to announce that the Centers for Medicare and Medicaid Services (CMS) has included the Patient Activation Measure Performance Measure (PAM-PM) in its Merit-Based Incentive Payment System (MIPS), as well as in 15 specialty-specific measure sets and five MIPS Value Pathways (MVPs), subsets of measures for specific conditions. The Patient Activation... Read More
WILMINGTON, Del. / Nov 08, 2023 / Business Wire / Phreesia today announced its patient intake platform and data centers have earned certified status by HITRUST for information security. We believe HITRUST Risk-based, 2-year (r2) Certified status demonstrates that Phreesia’s intake platform and data centers have met demanding regulatory compliance and industry-defined requirements and are appropriately managing risk. This... Read More
WILMINGTON, Del. / Nov 01, 2023 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2024 financial results after the close of market trading on Tuesday, December 5, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com... Read More
WILMINGTON, Del. / Sep 06, 2023 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2023. "I am incredibly pleased and proud of our team’s accomplishments in the second quarter of fiscal year 2024. We continued to deliver excellent value for our clients and scale our business—all while helping patients take a more active... Read More
WILMINGTON, Del. / Aug 16, 2023 / Business Wire / Phreesia , a leader in patient intake, outreach and activation, is pleased to announce it has been selected by The Software Report as one of the “ Top 100 Software Companies of 2023 .” The annual program evaluates companies based on a range of factors, including product functionality, innovative capabilities, environmental, social and governance (ESG) involvement, and... Read More
WILMINGTON, Del. / Aug 15, 2023 / Business Wire / On July 13, 2023, Phreesia, Inc.’s (“Phreesia”) Board of Directors approved the grant of restricted stock unit awards pursuant to Phreesia’s 2023 Inducement Award Plan (the “Plan”). On August 15, 2023, Phreesia made grants pursuant to the Plan in an aggregate amount of 12,285 shares of its common stock to 24 new non-executive employees to induce them to join Phreesia. The... Read More
WILMINGTON, Del. / Aug 14, 2023 / Business Wire / Phreesia , a leader in patient intake, outreach and activation, is pleased to announce it has acquired Access eForms, an innovative electronic forms management and automation provider that helps hospitals across the country streamline workflows, improve compliance and deliver a better patient experience. Access eForms has a vast catalogue of content as well as deep expertise... Read More
WILMINGTON, Del. / Aug 01, 2023 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal second quarter 2024 financial results after the close of market trading on Wednesday, September 6, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at... Read More
WILMINGTON, Del. / Jul 14, 2023 / Business Wire / Phreesia , a leader in patient intake, outreach and activation, is pleased to announce it has acquired Comsort, Inc. d/b/a MediFind (“MediFind”), a health technology company that uses advanced analytics to help patients—especially those with serious, chronic and rare diseases—find better care faster. MediFind uses machine learning and proprietary algorithms to continuously... Read More
WILMINGTON, Del. / Jul 13, 2023 / Business Wire / Phreesia is pleased to announce it has named Lisa Egbuonu-Davis, M.D., MPH, MBA, as the newest member of its board of directors, effective July 13, 2023. Dr. Egbuonu-Davis is the former Vice President, Medical Innovations for DH Diagnostics, LLC, an affiliate of Danaher Corporation, where she provided medical advice to influence research, partnership and investment strategy... Read More
WILMINGTON, Del. / May 31, 2023 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2023. "Our team got off to a solid start in fiscal 2024. Across the organization, we made meaningful progress toward achieving our goals of continued growth and a return to profitability, while maintaining our ongoing commitment to optimal... Read More
WILMINGTON, Del. / May 17, 2023 / Business Wire / Phreesia, a leader in patient intake, outreach and activation, has been selected by Modern Healthcare as one of the 2023 Best Places to Work in Healthcare . This is the seventh time Phreesia has been named to the list. “Phreesia is committed to fostering a positive workplace for our employees, and we’re thrilled to once again be named one of the Best Places to Work in... Read More
WILMINGTON, Del. / May 16, 2023 / Business Wire / Phreesia is pleased to announce that Hilary Hatch, PhD, Phreesia’s Chief Clinical Officer, has been named as one of the 2023 PM360 ELITE 100 by healthcare-marketing trade publication, PM360 . This year’s ELITE 100 were chosen from among 500 submissions across 19 categories. The PM360 ELITE Awards recognize individuals and teams who have made a significant impact on the... Read More
WILMINGTON, Del. / Apr 25, 2023 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2024 financial results after the close of market trading on Wednesday, May 31, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com.... Read More
CINCINNATI & WILMINGTON, Del. / Mar 29, 2023 / Business Wire / Unlimited Systems , a leading revenue cycle application provider for specialty healthcare, and Phreesia, a leader in patient intake, outreach and activation, are partnering to offer a new integration that allows independent oncology practices and health systems to enhance the patient experience and reduce staff burden. Through this partnership, organizations that... Read More
WILMINGTON, Del. / Mar 22, 2023 / Business Wire / Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, today announced the appointment of Balaji Gandhi as Phreesia’s Chief Financial Officer. Gandhi will succeed Randy Rasmussen, effective March 24, 2023. Rasmussen will serve as a Strategic Advisor to the Company for a period of time, to facilitate a smooth transition of his responsibilities. Gandhi... Read More
WILMINGTON, Del. / Mar 22, 2023 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2023. "There were many accomplishments and milestones achieved during Phreesia’s 18th year and fourth as a public company. We experienced challenges, opportunities and successes, and we greatly appreciate the hard work of... Read More
WILMINGTON, Del. / Mar 20, 2023 / Business Wire / Phreesia , a leader in patient intake, outreach and activation, is proud to announce that it has been named as one of the 2023 Achievers 50 Most Engaged Workplaces ® . This annual award recognizes top employers that display leadership and innovation in engaging their workplaces, with past winners including CVS Health, Discover, 3M and Samsung. In receiving this accolade,... Read More
WILMINGTON, Del. / Mar 17, 2023 / Business Wire / P hreesia is pleased to announce that the healthcare marketing industry trade publication MM+M has named Alexandra Beneville, Vice President, Life Sciences Content Strategy, to its Women to Watch class of 2023. Now in its eighth year, the program honors the industry’s “leaders of tomorrow”—women who have inspired their colleagues and “represent the best of what this industry... Read More
WILMINGTON, Del. / Mar 15, 2023 / Business Wire / Phreesia , a leader in patient intake, outreach and activation, is proud to announce that Dan Nathan, the company’s Chief Technology Officer, has been named to The Software Report ’s list of the Top 25 Software CTOs of 2023. Honorees were selected based on a proven record of high performance in leading teams to deliver solutions that streamline operations, improve efficiency... Read More
WILMINGTON, Del. / Feb 02, 2023 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal fourth quarter 2023 financial results after the close of market trading on Wednesday, March 22, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com... Read More
Healthcare Tech Leader Recognized in GEI, which Provides Insight into an Opaque Area of ESG Data Reporting WILMINGTON, Del. / Jan 31, 2023 / Business Wire / Phreesia , a leader in patient intake, outreach and activation, is joining 483 other companies as a member of the 2023 Bloomberg Gender-Equality Index (GEI). This reference index measures gender equality across five pillars: leadership and talent pipeline, equal pay and... Read More
WILMINGTON, Del. & NEW YORK / Jan 26, 2023 / Business Wire / Phreesia , a leader in patient intake, outreach and activation, along with the Ad Council, a nonprofit organization at the forefront of driving change through social impact marketing, have collaborated to bring three public health campaigns directly to patients and caregivers. Initial results show the campaigns are helping to raise awareness about critical health... Read More
Amneal Pharmaceuticals

COPYRIGHT ©2023 HEALTH STOCKS HUB